Prazosin: differential affinities for two populations of alpha-noradrenergic receptor binding sites.
D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000818:Animals; D003000:Clonidine / Q000378:metabolism; D004088:Dihydroergotoxine / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects* / Q000378:metabolism
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D010643:Phenoxybenzamine; D004088:Dihydroergotoxine; D003000:Clonidine; D011224:Prazosin; D010646:Phentolamine